DNMT1 and hepatocellular carcinoma: demonstrated that silencing PD‐L1 in aggressive HCC cell lines significantly inhibited DNMT1 expression, accompanied by global DNA hypomethylation and dysregulation of the tumour stem cell marker EpCAM.255